CB_INSIGHTS-ESP供应商评估矩阵——寿险承保数据平台(英文)-2021.6-75_73页_5mb
报告摘要
State Of Healthcare Q1'21 Report Summary
Core Content
The State of Healthcare Q1'21 Report provides an overview of investment trends and sector-specific developments in the global healthcare industry during the first quarter of 2021. It highlights the significant growth in funding, the role of digital health and AI in transforming healthcare, and the increasing focus on consumer-centric solutions and telehealth.
Main Trends and Findings
Global Healthcare Funding
- Total Funding: Reached a new quarterly record of $31.6B.
- Mega-Rounds: 96 mega-rounds (over $100M) were recorded, with North America seeing the highest growth in mega-rounds, doubling compared to previous quarters.
- Deal Count: Increased by 9% to 1,500+ deals, the second-highest in the last 12 quarters.
- Asia Decline: Funding in Asia dropped by 12% QoQ, marking the first decline since Q1’20.
Digital Health
- Funding: Jumped by 9% QoQ to $9B+, reaching an all-time high.
- Deal Count: Increased by nearly 13% to 1,500+ deals.
- Early-Stage Deals: Slightly increased, while late-stage deals declined by 1%.
AI in Healthcare
- Funding: Reached a new record of $2.5B, with 111 deals.
- Key Applications: AI was used in drug discovery, diagnostics, and patient payments.
- Notable Investments:
- Insitro raised $400M in a Series C round.
- Cedar raised $200M in a Series D round, achieving a valuation of $3.2B.
- Valo raised $190M in a Series A round, with a valuation of $400M.
- k Health raised $132M in a Series A round, with a valuation of $278M.
- AI M&A Activity: Data insights & analytics software was a key M&A category, with major players like UnitedHealth Group and Cigna acquiring AI-related firms.
Telehealth
- Funding: Reached a record $4.2B, with 130+ deals from 32 countries.
- Unicorns: Six telehealth companies became unicorns, with $1B+ valuations.
- Key Players:
- Oscar Health and Alignment Healthcare went public via IPO.
- MDLIVE and Doctor On Demand merged.
- Deal Count: Increased by 10% QoQ, the most on record.
Women's Health
- Funding: Increased to $964M, driven by Ro's $500M round.
- Early-Stage Focus: Nearly 70% of deals were early-stage, indicating strong interest in the sector.
Omics
- Funding: Declined QoQ to $1.8B across 39 deals.
- Mid- and Late-Stage Funding: Continued to receive significant investment, with 60% of deals in the US, a shift from a 3-year downward trend.
Health IT
- Funding: Doubled YoY to $1.8B.
- Early-Stage Deals: Fell to 7% of total deals, the lowest in recent quarters.
- Key Players:
- PointClickCare raised $21.4M in a Series A round.
- AKASA raised $60M in a Series B round, focusing on revenue cycle management.
Medical Devices
- Funding: Reached $4.6B, a 23% decline from Q4'20's peak.
- Deal Count: Fell by nearly 11% QoQ.
- Mega-Rounds: Focused on digital pathology and point-of-care testing (POCT).
Mental Health
- Funding: Increased by 54% QoQ to $852M, driven by late-stage deals in the employers market.
- Deal Count: Grew by 14% to 64 deals.
Consumer-Centric Solutions
- Growth: Increasing focus on accessibility, transparency, and personalization.
- Key Players:
- Best Buy announced plans to expand consumer health products.
- Owlet and DocGo focused on remote patient monitoring and mobile medical services.
Healthcare Market Drivers
- Long-Term Effects of Covid-19: Shifted focus from immediate pandemic response to telehealth integration and care delivery transformation.
- Regulatory Focus: CMS and other organizations are pushing for innovation in care delivery, especially for seniors and Medicare/Medicaid populations.
Key Acquisitions and M&As
- Appress Health acquired PatientPing.
- Cigna acquired MDLIVE.
- Nuance Communications acquired Saykara.
- GetWellNetwork acquired Docent Health.
- Cedar Gate acquired Enli.
SPAC Announcements
- Talkspace announced a SPAC deal with Hudson Executive Capital.
- 23andMe announced a SPAC deal with VG Acquisition.
- Sharecare and Owlet also announced SPAC deals.
Top New Unicorns in Q1'21
- PointClickCare: Valuation of $4B.
- Cedar: Valuation of $3.2B.
- Hinge Health: Valuation of $3B.
- Atai Life Sciences: Valuation of $2B.
- Aledade: Valuation of $1.9B.
Summary of Sector-Specific Highlights
- AI: Continued to attract major investment and attention, with 1.2K+ deals.
- Telehealth: Dominated the market with $4.2B in funding.
- Women's Health: Showed strong growth with $964M in funding.
- Omics: Continued to be a key area for mid- and late-stage investments.
- Health IT: Experienced significant funding growth with $1.8B.
- Medical Devices: Slightly declined in funding and deal count, but still a key sector.
- Mental Health: Grew by 54% in Q1'21, showing rising interest in the field.
Conclusion
The healthcare industry in Q1'21 was marked by record funding, increased deal activity, and notable shifts in focus toward digital health, telehealth, and AI-driven solutions. While Asia saw a decline in funding, North America and Europe remained strong. The consumer-centric approach and telehealth expansion were central themes, with AI and data analytics playing a pivotal role in driving innovation and improving care delivery.
试读结束,高清完整版pdf/doc/ppt,请点下载